Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s diseaseRobert Gilmore, Jakob Begun, Yoon‐Kyo An et al.|Intestinal Research|2025Cited by 8
Acute Severe Ulcerative Colitis Patients From Asia Have Lower Colectomy Risk Than Patients From AustralasiaRichard Fernandes, Yoon‐Kyo An, Dong Hyun Kim et al.|Clinical Gastroenterology and Hepatology|2025Cited by 1